APA

Van Eldik L. J., Sawaki L., Bowen K., Laskowitz D. T., Noveck R. J., Hauser B., Jordan L., Spears T. G., Wu H., Watt K., Raja S., Roy S. M., Watterson D. M. & Guptill J. T. (20211214). First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers. : Clinical pharmacology in drug development.

Chicago

Van Eldik Linda J, Sawaki Lumy, Bowen Karen, Laskowitz Daniel T, Noveck Robert J, Hauser Byron, Jordan Lynn, Spears Tracy G, Wu Huali, Watt Kevin, Raja Shruti, Roy Saktimayee M, Watterson D Martin and Guptill Jeffrey T. 20211214. First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers. : Clinical pharmacology in drug development.

Harvard

Van Eldik L. J., Sawaki L., Bowen K., Laskowitz D. T., Noveck R. J., Hauser B., Jordan L., Spears T. G., Wu H., Watt K., Raja S., Roy S. M., Watterson D. M. and Guptill J. T. (20211214). First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers. : Clinical pharmacology in drug development.

MLA

Van Eldik Linda J, Sawaki Lumy, Bowen Karen, Laskowitz Daniel T, Noveck Robert J, Hauser Byron, Jordan Lynn, Spears Tracy G, Wu Huali, Watt Kevin, Raja Shruti, Roy Saktimayee M, Watterson D Martin and Guptill Jeffrey T. First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers. : Clinical pharmacology in drug development. 20211214.